ID: ALA4551759

Max Phase: Preclinical

Molecular Formula: C10H10ClNO

Molecular Weight: 195.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(OC(C)C#N)c(Cl)c1

Standard InChI:  InChI=1S/C10H10ClNO/c1-7-3-4-10(9(11)5-7)13-8(2)6-12/h3-5,8H,1-2H3

Standard InChI Key:  ASEWTRRYTQQPLY-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-3/gamma-2 1565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.65Molecular Weight (Monoisotopic): 195.0451AlogP: 2.94#Rotatable Bonds: 2
Polar Surface Area: 33.02Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.04CX LogD: 3.04
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.73Np Likeness Score: -1.62

References

1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S..  (2018)  Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators.,  62  (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859]

Source